Angy (China) Medical Limited is the exclusive distributor for Australian AtCor SphygmoCor Cardiovascular Management System in China. In order to meet the market needs and deepen distributors' knowledge on Angy's general status, market situation and product features, the product marketing manager based in Angy's  headquarter in Guangzhou paid a special visit to Angy's Beijing office from August 1^st to August 3^rd to give a comprehensive and professional product training to some large distributors in North China.

At the beginning of the training, the marketing product manager gave a full introduction of Angy’s profile, the current situation of cardiovascular disease in China, AtCor SphygmoCor Cardiovascular Management System as well as its absolute advantages compared with the competing products.

During this training, the marketing product manager laid emphasis on the multi-functions of SphygmoCor Cardiovascular Management System, including non-invasive management of central blood pressure, arterial stiffness, Aix and HRV. This device has obtained many certificates, including FDA certificate and CE mark.  Internationally acknowledged as the gold standard for cardiovascular management and widely accepted by clinicians, AtCor SphygmoCor Cardiovascular Management System takes up the largest market share of its kind worldwide.

With this opportunity, the distributors not only kept comprehensive records, but also put forward some questions about this device to exchange their ideas with the marketing product manager. The marketing product manager explained profound theories in simple and vivid language so that the whole training processed with good interaction and in harmonious atmosphere. The distributors spoke highly of this training and expressed their hope to build up long-term partnership with Angy.

We would like to express our gratitude to Angy’s staff in Beijing office for their substantial support to this training.